Sirnaomics Ltd. (HKG:2257)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.08
-0.19 (-3.03%)
Jul 7, 2025, 11:47 AM HKT
41.72%
Market Cap 654.23M
Revenue (ttm) 13.81M
Net Income (ttm) -399.12M
Shares Out 104.34M
EPS (ttm) -5.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 340,800
Average Volume 660,018
Open 6.28
Previous Close 6.27
Day's Range 6.00 - 6.51
52-Week Range 2.35 - 6.95
Beta -0.21
RSI 81.37
Earnings Date Aug 29, 2025

About Sirnaomics

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates include STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; and STP707 to treat solid tumors. The company is also developing STP122G for the treatment of coagulation disorders;... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 69
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2257
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.